Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes (Q42165343)
Jump to navigation
Jump to search
scientific article published on May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes |
scientific article published on May 2008 |
Statements
1 reference
Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes (English)
1 reference
1 reference
Coen D A Stehouwer
1 reference
Casper G Schalkwijk
1 reference
Søren S Lund
1 reference
Tom Teerlink
1 reference
Jørgen Gram
1 reference
Kaj Winther
1 reference
Merete Frandsen
1 reference
Ulla M Smidt
1 reference
Hans-Henrik Parving
1 reference
Allan A Vaag
1 reference
1 reference
Identifiers
1 reference